Trial intelligence / Profile preview

Accordion Pill Carbidopa/Levodopa in Fluctuating Parkinson's Disease

NCT02605434Phase 3Unknown

Sponsor
Intec Pharma Ltd.
Start
Mar 2016
Primary completion
Jul 2019
Modality
Small Molecules
Countries
10
01

Overview

A Phase 3 trial of carbidopa + levodopa in Parkinson's disease (PD), sponsored by Intec Pharma Ltd.. Status: unknown.

02

Drugs

carbidopa + levodopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT02605434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02605434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call